Direct comparison of the diagnostic value of point-of-care tests detecting heart-type fatty acid binding protein or glycogen phosphorylase isoenzyme BB in patients with acute coronary syndromes with persistent ST-segment elevation

Kardiologia Polska

Volumn 69, Issue 1, 2011, Pages 1-6

  Figiel, Łukasz ^a   Wraga, Małgorzata ^a   Bednarkiewicz, Zbigniew ^a   Lipiec, Piotr ^a   Śmigielski, Janusz ^b   Krzemińska Pakuła, Maria ^a   Kasprzak, Jarosław D ^a  

^a Medical University of Lodz Bieganski Hospital   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Acute coronary syndrome; GP BB; h FABP; Markers of necrosis; Myocardial infarction

Indexed keywords

FATTY ACID BINDING PROTEIN; GLYCOGEN PHOSPHORYLASE B; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEART MUSCLE CELL; HEART MUSCLE NECROSIS; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POINT OF CARE TESTING; PREDICTIVE VALUE; QUALITATIVE ANALYSIS; QUANTITATIVE DIAGNOSIS; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN; VARIANT ANGINA PECTORIS;

EID: 79952231377     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Poloński L, Ga̧sior M, Gierlotka M et al. Epidemiologia, leczenie i rokowanie w ostrych zespołach wieńcowych na Śla̧sku - rejestr PL-ACS. Kardiol Pol, 2005; 62: 122-127.
2. Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J, 2007; 28: 2525-2538.
3. Glatz JF Van der Vusse GJ. Cellular fatty binding proteins. Their function and physiological significance. Prog Lipid Res, 1996; 35: 243-282.
4. Ishii J, Wang J, Naruse H et al. Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid binding protein in early detection of acute myocardial infarction. Clin Chem, 1997; 43: 1372-1378. (Pubitemid 27329784)
5. Wodzig KW, Kragten JA, Hermens WT et al. Estimation of myocardiac infarct size from plasma myoglobin or fatty-acid binding protein. Influence of renal function. Eur J Clin Chem Clin Bioch, 1997; 35: 191-198. (Pubitemid 27192977)
6. Van Nieuwenhoven FA, Kleine AH, Wodzig KW et al. Discrimination between myocardial and sceletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation, 1995; 92: 2848-2854.
7. Wu AH, Graff L, Petry Ch et al. Role of heart fatty acid binding protein in early detection of acute myocardial infarction. Clin Chem, 2000; 46: 718-719. (Pubitemid 30318431)
8. Kaptein H, Chan C, Sanderson J et al. Early detection of acute myocardial infarction with the new marker fatty acid binding protein:rapid testing and diagnostic value. Biosensor Symposium, Tubingen 2001.
9. Newgard CB, Hwang PK, Fletterick RJ. The family of glycogen phosphorylases: structure and function. Crit Rev Biochem Mol Biol, 1989; 24: 69-99.
10. Newgard CB, Littmann DR, Genderen C et al. Human brain glycogen phosphorylase: cloning sequence analysis, chromosomal mapping, tissue expression and comparison with the human liver and muscle isoenzymes. J Biol Chem, 1988; 263: 3850-3857. (Pubitemid 18078978)
11. Rabitzsch G, Mair J, Lechleitner P et al. Isoenzyme BB of glycogen phosphorylase b and myocardial infarction (letter). Lancet, 1993; 241: 1032-1033.
12. Proskova J, Stejskal D, Lacnak B et al. Glycogenphosphorylase BB in the early diagnosis of ACS. Clin Chem Lab Med, 2007; S1: W288.
13. Mair P, Puschendorf B, Smidt J et al. Early release of glycogen phosphorylase in patients with unstable angina and transient ST-T alterations. Br Heart J, 1994; 72: 125-127. (Pubitemid 24251461)
14. Okamoto F, Sohmiya K, Ohkaru Y et al. Human heart-type cytoplasmic fatty acid-binding protein for the diagnosis of acute myocardial infarction. Clinical evaluation of h-FABP in comparison with myoglobin and creatin kinase isoenzyme MB. Clin Chem Lab Med, 2003; 38: 231-238.
15. Suzuki M, Hori S, Noma S et al. Prognostic value of a novel qualitative analysis for heart type fatty acid-binding protein in patients with acute coronary syndrome in the emergency department. Acad Emerg Med, 2004; 11: 569.
16. Chan CP, Sanderson JE, Glatz JF, Cheng WS, Hempel A, Renneberg R. A superior early myocardial infarction marker-human heart-type fatty acid-binding protein. Z Kardiol, 2004; 93: 388-397. (Pubitemid 38736834)
17. Pagani F, Bonora R, Bonetti G et al. Evaluation of sandwich enzyme linked immunoabsorbent assay for the measurement of serum fatty acid-binding protein. Ann Clin Biochem, 2002; 39: 404-495.
18. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tussue injury. Clin Chim Acta, 2005; 352: 15-35. (Pubitemid 40093855)
19. Figiel Ł, Kasprzak JD, Peruga JZ et al. Heart-type fatty acid binding protein-a reliable marker of myocardial necrosis in a heterogenous group of patients with acute coronary syndrome without persistent ST elevation. Kardiol Pol, 2008; 66: 253-258.
20. Haltern G, Peiniger S, Bufe A et al. Comparison of usefulness of heart-type faty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction. The American Journal of Cardiology 2010 (www.AJConline.org).
21. Peetz D, Post F, Schinzel H et al. Glycogen phosphorylase BB in acute coronary syndromes. Clin Chem Lab Med, 2005; 43: 1351-1358.
22. Rabitzsch G, Mair J, Lechleitner P et al. Isoenzyme BB of glycogen phosphorylase b and myocardial infarction. Lancet, 1993; 341: 1032-1033. (Pubitemid 23109217)
23. Mair J, Puschendorf B, Smidt J et al. Early release of glycogen phosphorylase in patients with unstable angina and transient ST-T alteration. Br Heart J, 1994; 72: 125-127. (Pubitemid 24251461)
24. McCann CJ, Glover BM, Menown IBA et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J, 2008; 29: 2843-2850.